Case Presentations: How Therapeutic Advances in Glaucoma Could Improve Patient Care
Media formats available:
Details
Presenters
Overview
GRANTOR STATEMENT Supported through an educational grant from Aerie Pharmaceuticals. Learning Objectives
Upon completion of this activity, participants will be better able to: - Discuss the chemical structure and mechanism of action of topical glaucoma medications and evolving neuroprotective medications.
- Explain the anti-fibrotic activity in novel drug classes.
- Evaluate novel therapeutics and classes of drugs and their potential for enhanced patient compliance.
Accreditation
Accreditation Statement Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In cooperation with Evolve Medical Education LLC, the University of Houston College of Optometry has reviewed and endorsed this course. Evolve is an approved COPE Administrator. This course is COPE approved for 1.0 hours of CE Credit for Optometrists. COPE Course ID: 61669-GL COPE Event ID: 117060 COPE EXPIRATION DATE: March 4, 2022 Participation Method
TO OBTAIN CREDIT To obtain credit for this activity, you must read the activity in its entirety and complete the Pretest/Posttest/Activity Evaluation/Satisfaction Measures Form, which consists of a series of multiple choice questions.
Faculty and Disclosures
DISCLOSURE POLICY
Janet B. Serle, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals. Allergan, plc., and Bausch & Lomb. Grant/Research Support: Allergan plc, and Ocular Therapeutics. Stock Options: Aerie Pharmaceuticals. Thomas Samuelson, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: AcuMEMS; Aerie Pharmaceuticals; Akorn; Alcon Surgical; AMO (Abbott Medical Optics) AqueSys; Bausch and Lomb; BELKIN Laser; Endo Optics; Equinox; Glaukos Corporation; and Ivantis; Ocular Surgery News; PolyActiva, Santen Pharmaceutical Co, Ltd; Shire Plc; Transcend Medical, Veracity Innovations, LLC; and Vindico/Slack. Stock Options: Equinox; Glaukos Corporation; and Ivantis. Editorial Support Disclosures Erin K. Fletcher, MIT, director of compliance and education, Susan Gallagher-Pecha, director of client services and project management, Evolve; and Michelle Dalton, writer have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has no financial relationships with commercial interests.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
Off-Label Statement This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie Pharmaceuticals. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!